Of 89 patients admitted to coronary care after myocardial infarction, 27 per cent developed radioisotopic evidence of deep venous thrombosis. This complication occurred more frequently if the patient was over 6o years, if there was a previous history of angina pectoris, and if heart failure or a significant dysrhythmia developed. A group of patients with a low incidence of deep venous thrombosis was also identified.
It has been established by the use of radioactive fibrinogen that deep venous thrombosis of the lower limb occurs in approximately one-third of patients admitted to hospital with acute myocardial infarction (Nicolaides et al., I971; Murray et al.,  I970; Maurer, Wray, and Shillingford, I97I; Simmons, Sheppard, and Cox, I972; Handley, Emerson, and Fleming, I972) .
The aim of this study is to identify those patients who are especially likely to develop deep venous thrombosis. section of the proforma was completed within 2 days of the patients' discharge from hospital. This 'final assessment' was used to confirm or refute the diagnosis of myocardial infarction which depended upon the occurrence of characteristic electrocardiographic abnormalities and rise in serum levels of aspartate transaminase and lactic dehydrogenase. These enzymes were determined daily for 3 days after admission. Of the 94 patients studied, 5 were rejected as not fulfilling the diagnostic requirements.
Patients and methods
Anticoagulants were not used routinely. Some of the patients who developed deep venous thrombosis or features suggesting mural thrombosis in the heart (Simmons et al., 1972) more likely to occur in patients over the age of 6o, in those with a previous history of angina pectoris, and in those who develop left or congestive heart failure or significant dysrhythmias. An increased incidence, not reaching statistical significance, was also found in women and patients with a history of varicose veins or previous myocardial infarction. These results extend the findings of Maurer et al. (I97I). Using the same method they observed that deep venous thrombosis was more likely to complicate myocardial infarction ifthe patients had existing varicose veins, were over 70 years old, or had 'a severe complicated illness'. Their findings were not shown to be statistically significant.
In this study duration of pain, site of infarction, the presence of a third heart sound, and the height of the serum enzyme levels had no predictive value.
Patients with one or more statistically significant high risk features were grouped together and their incidence of deep venous thrombosis is compared in Table 3 with that of the remainder.
The difference between the groups is highly significant. It can be inferred from this Whether or not detection of venous thrombosis in these patients leads to a reduction in morbidity or mortality from pulmonary embolism is difficult to assess. In 6 patients there was evidence that thrombosis in calf or popliteal veins was extending.
These patients were anticoagulated following the suggestion of Kakkar et al. (I969) . No patient developed major pulmonary embolism though one patient in whom there was no evidence of deep venous thrombosis died suddenly in his fourth week in hospital. Necropsy was not allowed and it remains possible that he died of major pulmonary embolism.
Three patients were thought to develop minor pulmonary infarction; all had evidence of deep venous thrombosis and none had been anticoagulated. It is well known that minor pulmonary embolism is difficult to diagnose and its true incidence in the patients in this study remains unknown.
It is theoretically possible that intravenous injection of human fibrinogen can transmit serum hepatitis. None of the patients in this study subsequently developed symptomatic hepatitis. One patient developed a rash due to oral potassium iodide given to block thyroid uptake of 125I. 
